In May 2022, the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA) announced the launch of a new program for expediting the development of new treatment options for rare diseases Accelerating Rare disease Cures (ARC) Program.1 The FDA considers a disease that affects fewer than 200,000 people in the U.S. a rare disease, and estimates that more than 30…
Wilson Sonsini partner Kathy Ku was recently honored as a leading attorney in both the region of Los Angeles and the state of California. On May 17, 2022, Los Angeles Business Journal named Kathy as one of the “Top 100 Lawyers” in the Los Angeles region for her ongoing efforts as an outstanding legal professional. The accompanying profile covers Kathy’s career in legal work, which stretches from…
Executive Order 11246 (the "Executive Order") and Federal Acquisition Regulation (FAR) contract clause 52.222-26 (the "FAR Clause") long have imposed important employment-related requirements on government contractors and subcontractors. New rules now require certifications by June 30, 2022 regarding compliance with affirmative action obligations.
Companies that have a contract (a "Prime…
On April 12, 2022, the Colorado Attorney General s Office released "Pre-Rulemaking Considerations for the Colorado Privacy Act," which provides a series of topics and questions for which the office seeks informal public feedback.1 Here is what you need to know:
The Colorado Attorney General s Office is currently seeking informal input to guide its future rulemaking efforts. While, at this phase,…
In April 2022, Law.com International published The Asia Legal Awards 2022 shortlists for both firm and individual awards. Wilson Sonsini partner Dan Ouyang has been selected as a finalist for "IPO Lawyer of the Year." The awards ceremony will be held on June 15, 2022, in Hong Kong.
The Asia Legal Awards honor the best work in Asia, identifying the most important transactions and cases with the…